Clinical Read2026-10-12

Efzimfotase alfa (ALXN1850) - (HICKORY)

Name: Efzimfotase alfa (ALXN1850) - (HICKORY)
Start: 2026-10-12

AstraZeneca PLCAZN

Indication: Adolescents (12 to <18 years of age) and adults with hypophosphatasia (HPP)
Stage: phase3
Event: Phase 3
Source: View catalyst source ↗